78 results
Page 3 of 4
424B3
mlb05wxucq1p y9jd
2 Jun 21
Prospectus supplement
10:09am
424B3
l7h3qw82xvwb
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
3kvn1onbzy
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
gmbxt uutt6907th6
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
20-F
EX-2.7
p6nq xc3q
30 Apr 21
Annual report (foreign)
12:53pm
20-F
cxjram 12jw90t8gwdf3
30 Apr 21
Annual report (foreign)
12:53pm
424B3
7ezyz66zc0lg4y0mk5
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
k5ps5282mi szn
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
dwlvps784 sum7pm69wb
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
gtal0qjfh8 de
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
9gnvinx
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
6fxjdh67sip
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.1
kyvfvfzt wnxns
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-10.2
arn1cp ktoelnwkccj
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
hbhw5hdrfe1is6
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
e5w9ll 98o479
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
ryamv1t
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
pj9 902447gxgmp
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
8bdv25u5
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
ztws58xlh3l6
6 Jul 20
Registration statement (foreign) (amended)
5:28pm